Lantheus Holdings (LNTH) Payables (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Payables came in at $45.9 million in Q1 2026, up 2.23% year-on-year from $44.9 million in Q1 2025, and up 6.92% on a QoQ basis from $42.9 million in Q4 2025.
Lantheus Holdings (LNTH) Payables (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Payables data on file, last reported at $45.9 million in Q1 2026.
- On a quarterly basis, Payables rose 2.23% year-over-year to $45.9 million in Q1 2026; TTM through Mar 2026 was $45.9 million, a 2.23% increase from a year earlier, with the FY2025 full-year figure at $42.9 million, up 24.15% from the prior year.
- Payables for Q1 2026 stood at $45.9 million, up from $42.9 million in the prior quarter.
- Over the last five years, Payables for LNTH reached as high as $66.3 million in Q3 2025 and fell as low as $20.6 million in Q4 2022.
- Historically, Payables has averaged $38.2 million across 5 years, with a median of $38.9 million in 2023.
- Across the five-year window, Payables surged 100.31% in 2023 and dropped 17.85% in 2025, its largest moves.
- Year by year, Payables stood at $20.6 million in 2022, then surged by 100.31% to $41.2 million in 2023, then retreated by 16.09% to $34.6 million in 2024, then grew by 24.15% to $42.9 million in 2025, then grew by 6.92% to $45.9 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $45.9 million in Q1 2026, $42.9 million in Q4 2025, and $66.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 45.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.88 Mn |
| Dec 31, 2025 | 42.91 Mn |
| Sep 30, 2025 | 66.30 Mn |
| Jun 30, 2025 | 40.89 Mn |
| Mar 31, 2025 | 44.87 Mn |
| Dec 31, 2024 | 34.56 Mn |
| Sep 30, 2024 | 44.91 Mn |
| Jun 30, 2024 | 49.77 Mn |
| Mar 31, 2024 | 37.53 Mn |
| Dec 31, 2023 | 41.19 Mn |
| Sep 30, 2023 | 37.08 Mn |
| Jun 30, 2023 | 38.86 Mn |
| Mar 31, 2023 | 30.80 Mn |
| Dec 31, 2022 | 20.56 Mn |
| Sep 30, 2022 | 30.14 Mn |
| Jun 30, 2022 | 21.15 Mn |
| Mar 31, 2022 | 22.38 Mn |
| Dec 31, 2021 | 20.79 Mn |
| Sep 30, 2021 | 20.51 Mn |
| Jun 30, 2021 | 21.47 Mn |